The Effects of 6 Common Antidiabetic Drugs on Anti-PD1 Immune Checkpoint Inhibitor in Tumor Treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Effects of 6 Common Antidiabetic Drugs on Anti-PD1 Immune Checkpoint Inhibitor in Tumor Treatment
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2022, Issue -, Pages 1-24
Publisher
Hindawi Limited
Online
2022-08-19
DOI
10.1155/2022/2651790
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- On the mechanism of sitagliptin inhibition of colorectal cancer cell lines’ metastatic functionalities
- (2021) Rubén Varela‐Calviño et al. IUBMB LIFE
- Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
- (2021) Hyunkoo Kang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
- (2021) Hong Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Acarbose improved survival for Apc +/Min mice
- (2020) Sherry G. Dodds et al. AGING CELL
- Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis
- (2020) Xiao-Yong Huang et al. Molecular Cancer
- Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma-associated antigen-A3 expression through Yes-associated protein inactivation
- (2020) Qi Wang et al. Cancer Medicine
- The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer
- (2020) Rachael M. Orlandella et al. Cancers
- Sitagliptin Modulates the Response of Ovarian Cancer Cells to Chemotherapeutic Agents
- (2020) Agnieszka Kosowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth
- (2019) Clémence Hollande et al. NATURE IMMUNOLOGY
- Incident Hepatocellular Carcinoma Risk in Patients Treated with a Sulfonylurea: A Nationwide, Nested, Case-Control Study
- (2019) Ji-Yeon Lee et al. Scientific Reports
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Thiazolidinediones: the Forgotten Diabetes Medications
- (2019) Harold E. Lebovitz Current Diabetes Reports
- Anti-diabetic medications and the risk for colorectal cancer: A population-based nested case-control study
- (2019) Cheol Min Shin et al. Cancer Epidemiology
- Pharmacotherapy of type 2 diabetes: An update
- (2018) Jagriti Upadhyay et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
- (2018) Jong-Ho Cha et al. MOLECULAR CELL
- Association of Pioglitazone with Increased Risk of Prostate Cancer and Pancreatic Cancer: A Functional Network Study
- (2018) Weiheng Wen et al. Diabetes Therapy
- Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence
- (2017) Charles E. Leonard et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals
- (2016) Bendix Carstensen et al. DIABETOLOGIA
- Use of an α-Glucosidase Inhibitor and the Risk of Colorectal Cancer in Patients With Diabetes: A Nationwide, Population-Based Cohort Study
- (2015) Yao-Hsien Tseng et al. DIABETES CARE
- Sitagliptin and pancreatic cancer risk in patients with type 2 diabetes
- (2015) Chin-Hsiao Tseng EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Cancer risk in patients with type 2 diabetes mellitus and their relatives
- (2015) Xiangdong Liu et al. INTERNATIONAL JOURNAL OF CANCER
- An Updated Review on Cancer Risk Associated with Incretin Mimetics and Enhancers
- (2015) Chin-Hsiao Tseng et al. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS
- Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
- (2015) Rosa Barreira da Silva et al. NATURE IMMUNOLOGY
- The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice
- (2015) NAOKI YORIFUJI et al. ONCOLOGY REPORTS
- Diabetes mellitus: influences on cancer risk
- (2014) Leszek Szablewski DIABETES-METABOLISM RESEARCH AND REVIEWS
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Conventional Hypoglycaemic Agents and the Risk of Lung Cancer in Patients with Diabetes: A Meta-Analysis
- (2014) Ying Wu et al. PLoS One
- Pioglitazone and Cancer: Angel or Demon?
- (2013) Michael Kostapanos et al. CURRENT PHARMACEUTICAL DESIGN
- Insulin Therapy and Cancer
- (2013) P. Home DIABETES CARE
- Insulin therapy contributes to the increased risk of colorectal cancer in diabetes patients: a meta-analysis
- (2013) Lei Wang et al. Diagnostic Pathology
- Risk of Bladder Cancer in Diabetic Patients Treated with Rosiglitazone or Pioglitazone: A Nested Case–Control Study
- (2013) Fei-Yuan Hsiao et al. DRUG SAFETY
- Metformin: an old drug with new potential
- (2013) Joud Hajjar et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats
- (2013) Angelo Pietro Femia et al. INTERNATIONAL JOURNAL OF CANCER
- Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-analysis using primary data of published studies
- (2013) Bindiya Thakkar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus
- (2012) Chia-Hsuin Chang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study
- (2012) Ronac Mamtani et al. JNCI-Journal of the National Cancer Institute
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
- (2011) C. Piccinni et al. DIABETES CARE
- Prospective Study Reveals Associations Between Colorectal Cancer and Type 2 Diabetes Mellitus or Insulin Use in Men
- (2010) Peter T. Campbell et al. GASTROENTEROLOGY
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Diabetes and cancer
- (2009) Paolo Vigneri et al. ENDOCRINE-RELATED CANCER
- Effects of Pioglitazone, a Peroxisome Proliferator–Activated Receptor Gamma Agonist, on the Urine and Urothelium of the Rat
- (2009) Shugo Suzuki et al. TOXICOLOGICAL SCIENCES
- Insulin Therapy and Colorectal Adenoma Risk Among Patients with Type 2 Diabetes Mellitus: A Case-Control Study in Korea
- (2008) Yong Woo Chung et al. DISEASES OF THE COLON & RECTUM
- Primary care physicians and insulin initiation: multiple barriers, lack of knowledge or both?
- (2008) S Jabbour INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus
- (2008) Bethany B. Barone JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started